
Sahika Pharmaceuticals Private Limited
About Sahika Pharmaceuticals Private Limited
Data last updated:
Sahika Pharmaceuticals Private Limited is a private limited company based in Delhi, India, recognised as a startup by DPIIT. It operates in the medical and laboratory equipment segment of the healthcare sector. It was incorporated on 09 September 2021 and has been in existence for over 5 years.
The company is registered with the Registrar of Companies (ROC), Delhi, under CIN U74999DL2021PTC386308. Its GSTIN is 07ABGCS8166D1Z5 (Delhi). The company holds 3 GST registrations, of which 2 are active.
The company has an authorised share capital of ₹3 Cr and a paid-up capital of ₹3 Cr. It is led by directors including Seema Gupta and Sahil Gupta.
Its last annual general meeting (AGM) was held on 29 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at F No – 78 – D T/F A Pkt Budhela Extn, Delhi, India – 110018.
As per the financials filed for FY 2024, the company reported a revenue of ₹44.54 Lakh, a growth of 15% compared to the previous year. For the same year it recorded a net loss of ₹63.08 Lakh (net margin -141.6%) and EBITDA of ₹3.02 Lakh (EBITDA margin 6.8%).
As per MCA filings, the company has open charges of ₹8.24 Cr on record. Court records list 3 cases involving the company, including 2 filed by the company and 1 filed against it; 3 cases are pending.
Sahika Pharmaceuticals Private Limited is registered as a micro enterprise under the Udyam registration framework (Reg. No. UDYAM-DL-03-0012005).
Company details
Recognitions & Rankings of Sahika Pharmaceuticals
- Category
- Micro (2023-24)
- Udyam number
- UDYAM-DL-03-0012005
Contact details
Sahika Pharmaceuticals Private Limited's registered office is in Delhi, Delhi. Its e-mail address and telephone number are in the company report.
- Email
- Telephone
- Registered AddressF No – 78 – D T/F A Pkt Budhela Extn, Delhi, India – 110018
- IndustryHealthcare, Medical & Laboratory Equipment
To see the full contact details of Sahika Pharmaceuticals Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Business activity
The main business activity of Sahika Pharmaceuticals is manufacturing. In detail, this covers chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products.
| Main activity group code | Main activity | Business activity code | Business activity | Share of turnover |
|---|---|---|---|---|
| C | Manufacturing | C6 | Chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products |
To see the full business activity and turnover split of Sahika Pharmaceuticals Private Limited, buy the company report.
Financials of Sahika Pharmaceuticals Private Limited
FY 2025 filings availableSahika Pharmaceuticals Private Limited reported revenue of ₹44.54 Lakh (up 15% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue rose 15% in the latest year. EBITDA fell 83% in the latest year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profit and Loss Statement | |||
| Revenue from Operations | |||
| Other Income | |||
| Total Revenue | ₹44.54 Lakh | ||
| Cost of Materials Consumed | |||
| Employee Benefit Expense | |||
| Finance Costs | |||
| Depreciation and Amortisation | |||
| Other Expenses | |||
| Total Expenses | |||
| EBITDA | ₹3.02 Lakh | ||
| Profit Before Tax | |||
| Tax Expense | |||
| Net Profit (PAT) | -₹63.08 Lakh | ||
| Balance Sheet | |||
| Share Capital | |||
| Reserves and Surplus | |||
| Net Worth (Total Equity) | |||
| Long-term Borrowings | |||
| Short-term Borrowings | |||
| Trade Payables | |||
| Total Liabilities | |||
| Fixed Assets | |||
| Investments | |||
| Inventories | |||
| Trade Receivables | |||
| Cash and Bank Balance | |||
| Total Assets | |||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 |
|---|---|---|---|
| Profitability | |||
| EBITDA Margin | 6.8% | ||
| Net Profit Margin | -141.6% | ||
| Return on Equity (ROE) | |||
| Return on Capital Employed (ROCE) | |||
| Return on Assets (ROA) | |||
| Liquidity and Debt | |||
| Current Ratio | |||
| Quick Ratio | |||
| Debt-to-Equity Ratio | |||
| Interest Coverage Ratio | |||
| Efficiency and Growth | |||
| Asset Turnover | |||
| Receivable Days | |||
| Payable Days | |||
| Inventory Days | |||
| Revenue Growth | |||
| Net Profit Growth | |||
To see the full financial statements and ratios of Sahika Pharmaceuticals Private Limited, buy the company report.
Board of directors of Sahika Pharmaceuticals Private Limited
Sahika Pharmaceuticals has 3 directors on record. No former directors are listed.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Seema Gupta | Director | 01 Dec 2021 | 4 Years 11 Months | Current |
| Sahil Gupta Also directs: Genz Healthcare Private Limited, Sahika Marketing Solutions Private Limited, Asg Services Private Limited and 1 more | Director | 09 Sep 2021 | 5 Years 2 Months | Current |
| Mukesh Gupta | Director | 09 Sep 2021 | 5 Years 2 Months | Current |
Peer comparison
Sahika Pharmaceuticals Private Limited is compared with the 3 companies closest to it by revenue in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Axaj Pharmaceuticals Private Limited | ₹44.78 Lakh (FY 2024) | 374.0% | Ankleshwar, Gujarat, India | |||
| High Light Drugs and Pharmaceuticals Private Limited | ₹44.77 Lakh (FY 2025) | -1.0% | Gwalior, Madhya Pradesh, India | |||
| Sahika Pharmaceuticals Private Limitedthis company | ₹44.54 Lakh (FY 2024) | -₹63.08 Lakh | -141.6% | 15.0% | Delhi, India | |
| Globocare Pharmaceuticals Private Limited | ₹44.26 Lakh (FY 2023) | -20.0% | Pachim Vihar, Delhi, India |
To see the full peer comparison of Sahika Pharmaceuticals Private Limited, buy the company report.
Auditor
Sahika Pharmaceuticals Private Limited is audited by Ashish Goyal and Company for the financial year 2024.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| Ashish Goyal and Company | FY 2024 | 525526 |
Shareholding
The shareholding of Sahika Pharmaceuticals Private Limited is on record for 3 financial years, the latest being FY 2024, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|
| Promoters | |||
| Domestic institutional investors (DII) | |||
| Foreign institutional investors (FII) | |||
| Public | |||
| Others |
To see the full shareholding pattern of Sahika Pharmaceuticals Private Limited, buy the company report.
Charges & borrowings
| Date | Charge ID | Lender | Amount | Status | Modified or satisfied on |
|---|---|---|---|---|---|
| 30 May 2026 | 101321293 | Others | ₹40 Lakh | Open | |
| 16 Oct 2025 | 101167689 | Others | ₹20 Lakh | Open | |
| 03 Sep 2022 | 100610308 | Others | ₹7.64 Cr | Open |
To see the full charge records of Sahika Pharmaceuticals Private Limited, buy the company report.
Total charge records: 3 View all charges
Legal cases
Sahika Pharmaceuticals Private Limited has 3 court cases on record: 2 filed by Sahika Pharmaceuticals, 1 filed against it. All cases are pending.
Cases by court
| Court | Cases | Against the company | Pending |
|---|---|---|---|
| District courts | 2 | 0 | 2 |
| High courts | 1 | 1 | 1 |
Cases on record (3 of 3)
| Court | Type of case | Party | Status |
|---|---|---|---|
| Bombay High Court | Court case (LPETN) | Filed against the company by Aristo Pharmaceuticals Private Limited | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against Gainmed Biotech Pvt Ltd | Pending |
| District court, South West, Delhi | Cheque dishonour complaint | Filed by the company against an individual | Pending |
To see the full case history of Sahika Pharmaceuticals Private Limited, buy the company report.
Case records are compiled from court listings and may lag the court's own records. A case filed against a company is not a finding against it.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Sahika Pharmaceuticals Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
Sahika Pharmaceuticals has 3 GST registrations: 2 active and 1 cancelled or inactive.
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 07ABGCS8166D1Z5 | Delhi | Active | 06 Oct 2021 |
| 02ABGCS8166D1ZF | Himachal Pradesh | Active | 30 Oct 2021 |
To see the full GST registrations and return filing status of Sahika Pharmaceuticals Private Limited, buy the company report.
Recent activity
Sahika Pharmaceuticals Private Limited has 3 board changes on record since 2021: 3 appointments. The latest: Seema Gupta was appointed as Director on 01 Dec 2021.
Frequently asked questions
Sahika Pharmaceuticals is an active private limited company based in Delhi, India. The company works in medical and laboratory equipment, within the healthcare industry. It was incorporated on 09 September 2021 (5+ years old) and is registered under CIN U74999DL2021PTC386308.
Sahika Pharmaceuticals has 3 current directors:
- Seema Gupta - Director
- Sahil Gupta - Director
- Mukesh Gupta - Director
The latest financial statements of Sahika Pharmaceuticals on record with the MCA are for the year ended 31 March 2025. Its last annual general meeting was held on 29 September 2025. Year-wise statements from FY 2022 are in the company report.
The GSTIN of Sahika Pharmaceuticals is 07ABGCS8166D1Z5, registered in Delhi. The company has 3 GST registrations in all, of which 2 are active and 1 is cancelled or inactive. Other active GSTINs include 02ABGCS8166D1ZF (Himachal Pradesh).
The CIN (Corporate Identification Number) of Sahika Pharmaceuticals is U74999DL2021PTC386308. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Sahika Pharmaceuticals has 3 court cases on record: 2 filed by the company and 1 filed against it. 3 are pending. Most are in the district courts.
Sahika Pharmaceuticals was incorporated on 09 September 2021, making it 5+ years old. It is registered with the Registrar of Companies, Delhi.
The peers of Sahika Pharmaceuticals by revenue are Axaj Pharmaceuticals Private Limited, High Light Drugs and Pharmaceuticals Private Limited, Globocare Pharmaceuticals Private Limited, all in the Pharma industry (Pharmaceuticals), with the same principal business activity (chemical and chemical products, pharmaceuticals, medicinal chemical and botanical products).
Seema Gupta was appointed as Director on 01 Dec 2021. Mukesh Gupta was appointed as Director on 09 Sep 2021. Sahil Gupta was appointed as Director on 09 Sep 2021.
Yes, Sahika Pharmaceuticals is recognised as a startup by the Department for Promotion of Industry and Internal Trade (DPIIT).
Yes, Sahika Pharmaceuticals is registered as a micro enterprise under Udyam registration (number: UDYAM-DL-03-0012005).

